A Study to Learn About the Safety and Efficacy of the Drug Oleogel-S10 in Japanese Patients With Epidermolysis Bullosa

Clinical trial NCT06917690 · RECRUITING

Trial details

NCT number: NCT06917690
Sponsor: Chiesi Farmaceutici S.p.A.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Epidermolysis Bullosa Junctional Epidermolysis Bullosa Epidermolysis Bullosa, Dystrophic Epidermolysis Bullosa, Junctional Skin Abnormalities Connective Tissue Disease Collagen Diseases Skin Diseases Genetic Diseases, Inborn Congenital Abnormalities

Start date: 2025-04-18
Primary completion: 2026-03-01
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.